{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T06:02:21Z","timestamp":1789970541324,"version":"4.0.1"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T00:00:00Z","timestamp":1789948800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Polyendocrine Metabolic Ovarian Syndrome (PMOS) is a common endocrine disorder and a leading cause of anovulatory infertility. In women with PMOS, controlled ovarian stimulation (COS) often results in heterogeneous responses, with many oocytes of poor quality and lower fertilization rates. The combined use of recombinant Luteinizing Hormone (r-LH) and recombinant Follicle-Stimulating Hormone (r-FSH) has shown potential to improve Assisted Reproductive Technology (ART) outcomes in specific populations, such as women with hypogonadotropic hypogonadism or advanced age. However, its benefits in women with PMOS remain uncertain. This retrospective cohort study explores whether adding r-LH to r-FSH during COS improves reproductive outcomes in women with PMOS undergoing ART.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>The study included 156 women diagnosed with PMOS according to Rotterdam criteria, undergoing COS at a single tertiary center. After propensity score matching for age, body mass index (BMI), anti-M\u00fcllerian hormone (AMH), LH, and LH\/FSH ratio, 106 women were divided into two groups: 53 received r-LH\/r-FSH, and 53 received r-FSH alone. Baseline data, stimulation parameters, and ART outcomes were analyzed. Women in the r-LH\/r-FSH group required a higher cumulative FSH dose (2932\u00a0\u00b1\u00a0848 vs. 2455\u00a0\u00b1\u00a0588IU, p&amp;lt;0.002), produced more follicles on trigger day (13.91\u00a0\u00b1\u00a07.45 vs. 10.09\u00a0\u00b1\u00a05.55, p=0.014), and had more oocytes injected (13.81\u00a0\u00b1\u00a08.01 vs. 11.66\u00a0\u00b1\u00a05.57, p=0.0499). Multivariate analysis confirmed r-LH\/r-FSH was independently associated with increased follicular recruitment, regardless of AMH levels. However, stimulation protocol was not a significant predictor of oocyte count; age and AMH remained the primary factors. Total FSH dose was not associated with follicle number. No significant differences were observed in cumulative live birth rate; however, clinical pregnancy rate (CPR) after frozen embryo transfer (FET) was higher in the control group (54.5% vs. 25.0%, p=0.043).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Adding r-LH to r-FSH during COS in women with PMOS was associated with increased follicular recruitment but did not improve live birth or overall pregnancy rates. Notably, CPR after FET was lower with r-LH\/r-FSH. These findings suggest r-LH may modulate ovarian response, but further research is needed to clarify its role in ART protocols. Due to the retrospective, non-randomized design, these results are hypothesis-generating, and routine use of r-LH in this setting cannot currently be recommended.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fendo.2026.1909206","type":"journal-article","created":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T05:36:11Z","timestamp":1789968971000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Impact of adding r-LH to r-FSH during ovarian stimulation on reproductive outcomes of women with polyendocrine metabolic ovarian syndrome undergoing in vitro fertilization"],"prefix":"10.3389","volume":"17","author":[{"given":"In\u00eas","family":"Azevedo","sequence":"first","affiliation":[{"name":"Unit for Multidisciplinary Research in Biomedicine (UMIB), School of Medicine and Biomedical Sciences (ICBAS), University of Porto","place":["Porto, Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mafalda V.","family":"Moreira","sequence":"additional","affiliation":[{"name":"Unit for Multidisciplinary Research in Biomedicine (UMIB), School of Medicine and Biomedical Sciences (ICBAS), University of Porto","place":["Porto, Portugal"]},{"name":"i3S - Instituto de Investiga\u00e7\u00e3o e Inova\u00e7\u00e3o em Sa\u00fade, Universidade do Porto","place":["Porto, Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia S.","family":"Pereira","sequence":"additional","affiliation":[{"name":"Unit for Multidisciplinary Research in Biomedicine (UMIB), School of Medicine and Biomedical Sciences (ICBAS), University of Porto","place":["Porto, Portugal"]},{"name":"ITR - Laboratory for Integrative and Translational Research in Population Health","place":["Porto, Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Leal","sequence":"additional","affiliation":[{"name":"Unit for Multidisciplinary Research in Biomedicine (UMIB), School of Medicine and Biomedical Sciences (ICBAS), University of Porto","place":["Porto, Portugal"]},{"name":"Centre for Medically Assisted Procreation\/Public Gamete Bank, Gynecology Department, Centro Materno-Infantil do Norte Dr. Albino Aroso (CMIN), Centro Hospitalar Universit\u00e1rio de Santo Ant\u00f3nio (CHUdSA), Unidade Local de Sa\u00fade de Santo Ant\u00f3nio (ULSSA)","place":["Porto, Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e1rcia","family":"Barreiro","sequence":"additional","affiliation":[{"name":"Unit for Multidisciplinary Research in Biomedicine (UMIB), School of Medicine and Biomedical Sciences (ICBAS), University of Porto","place":["Porto, Portugal"]},{"name":"Centre for Medically Assisted Procreation\/Public Gamete Bank, Gynecology Department, Centro Materno-Infantil do Norte Dr. Albino Aroso (CMIN), Centro Hospitalar Universit\u00e1rio de Santo Ant\u00f3nio (CHUdSA), Unidade Local de Sa\u00fade de Santo Ant\u00f3nio (ULSSA)","place":["Porto, Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariana P.","family":"Monteiro","sequence":"additional","affiliation":[{"name":"Unit for Multidisciplinary Research in Biomedicine (UMIB), School of Medicine and Biomedical Sciences (ICBAS), University of Porto","place":["Porto, Portugal"]},{"name":"ITR - Laboratory for Integrative and Translational Research in Population Health","place":["Porto, Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Em\u00eddio","family":"Vale-Fernandes","sequence":"additional","affiliation":[{"name":"Unit for Multidisciplinary Research in Biomedicine (UMIB), School of Medicine and Biomedical Sciences (ICBAS), University of Porto","place":["Porto, Portugal"]},{"name":"ITR - Laboratory for Integrative and Translational Research in Population Health","place":["Porto, Portugal"]},{"name":"Centre for Medically Assisted Procreation\/Public Gamete Bank, Gynecology Department, Centro Materno-Infantil do Norte Dr. Albino Aroso (CMIN), Centro Hospitalar Universit\u00e1rio de Santo Ant\u00f3nio (CHUdSA), Unidade Local de Sa\u00fade de Santo Ant\u00f3nio (ULSSA)","place":["Porto, Portugal"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,21]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1093\/humupd\/dmaf030","article-title":"Prevalence of polycystic ovary syndrome: a global and regional systematic review and meta-analysis","volume":"32","author":"Neven","year":"2026","journal-title":"Hum Reprod Update"},{"key":"B2","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1093\/humupd\/dmw025","article-title":"The management of anovulatory infertility in women with polycystic ovary syndrome: an analysis of the evidence to support the development of global WHO guidance","volume":"22","author":"Balen","year":"2016","journal-title":"Hum Reprod Update"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1186\/1477-7827-11-56","article-title":"Obstetric complications in women with polycystic ovary syndrome: a systematic review and meta-analysis","volume":"11","author":"Qin","year":"2013","journal-title":"Reprod Biol Endocrinol"},{"key":"B4","doi-asserted-by":"publisher","first-page":"5591","DOI":"10.1038\/s41467-024-49749-1","article-title":"Systematic review and meta-analysis of pregnancy outcomes in women with polycystic ovary syndrome","volume":"15","author":"Bahri Khomami","year":"2024","journal-title":"Nat Commun"},{"key":"B5","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1186\/s13048-025-01621-6","article-title":"Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation","volume":"18","author":"Su","year":"2025","journal-title":"J Ovarian Res"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1210\/clinem\/dgad463","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"108","author":"Teede","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-023-09819-z","article-title":"Follicular fluid composition and reproductive outcomes of women with polycystic ovary syndrome undergoing in vitro fertilization: a systematic review","volume":"24","author":"Moreira","year":"2023","journal-title":"Rev Endocr Metab Disord"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2017.1412429","article-title":"Ovarian response to controlled ovarian stimulation in women with different polycystic ovary syndrome phenotypes","volume":"34","author":"Cela","year":"2018","journal-title":"Gynecol Endocrinol"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1007\/s40264-018-0742-3","article-title":"Safety of Follitropin Alfa\/Lutropin Alfa for stimulation of follicular development","volume":"42","author":"Abramova","year":"2019","journal-title":"Drug Saf"},{"key":"B10","volume-title":"Pergoveris: EPAR\u2014Product Information (Summary of Product Characteristics)","year":""},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.rbmo.2023.103725","article-title":"Effectiveness of recombinant human FSH: recombinant human LH combination treatment versus recombinant human FSH alone for assisted reproductive technology in women aged 35-40 years","volume":"48","author":"Bielfeld","year":"2024","journal-title":"Reprod BioMed Online"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.fertnstert.2018.01.003","article-title":"Recombinant luteinizing hormone supplementation in assisted reproductive technology: a systematic review","volume":"109","author":"Alviggi","year":"2018","journal-title":"Fertil Steril"},{"key":"B13","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1186\/s12958-021-00759-4","article-title":"Recombinant human luteinizing hormone co-treatment in ovarian stimulation for assisted reproductive technology in women of advanced reproductive age: a systematic review and meta-analysis of randomized controlled trials","volume":"19","author":"Conforti","year":"2021","journal-title":"Reprod Biol Endocrinol"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2026.1696657","article-title":"Optimizing mature oocyte yield in IVF: clinical comparison of r-hFSH+r-hLH and HMG in women with a stimulation dosage of at least 300 IU of gonadotropins","volume":"17","author":"Fatemi","year":"2026","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1016\/0303-7207(94)90278-x","article-title":"Follicular oestrogen synthesis: the 'two-cell, two-gonadotrophin' model revisited","volume":"100","author":"Hillier","year":"1994","journal-title":"Mol Cell Endocrinol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejogrb.2023.01.012","article-title":"Recombinant-luteinzing hormone supplementation in women during IVF\/ICSI cycles with GNRH-antagonist protocol: a systematic review and meta-analysis","volume":"283","author":"Hua","year":"2023","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.4274\/jtgga.galenos.2024.2023-12-9","article-title":"Impact of stimulation with luteinizing hormone activity on IVF outcomes in patients with polycystic ovary syndrome","volume":"25","author":"Kugelman","year":"2024","journal-title":"J Turk Ger Gynecol Assoc"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11061575","article-title":"Effect of rLH supplementation during controlled ovarian stimulation for IVF: evidence from a retrospective analysis of 1470 poor\/suboptimal\/normal responders receiving either rFSH plus rLH or rFSH alone","volume":"11","author":"Canosa","year":"2022","journal-title":"J Clin Med"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2026.1846779","article-title":"LH supplementation in ovarian stimulation: propensity score and generalized estimating equations analysis over 2000 embryos","volume":"17","author":"Dizdar","year":"2026","journal-title":"Front Endocrinol"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.5455\/medarh.2020.74.289-293","article-title":"Follicle stimulating hormone (LH: FSH) ratio in polycystic ovary syndrome (PCOS) - obese vs. non- obese women","volume":"74","author":"Saadia","year":"2020","journal-title":"Med Arch"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.1093\/oxfordjournals.humrep.a135742","article-title":"The prognostic value of basal luteinizing hormone:follicle-stimulating hormone ratio in the treatment of patients with polycystic ovarian syndrome by assisted reproduction techniques","volume":"10","author":"Tarlatzis","year":"1995","journal-title":"Hum Reprod"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.31083\/j.ceog5105126","article-title":"Polycystic ovary syndrome (PCOS): symptoms, causes, and treatment","volume":"51","author":"Bai","year":"2024","journal-title":"Clin Exp Obstet Gynecol"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1002\/wsbm.1558","article-title":"Hyperandrogenism and polycystic ovary syndrome: effects in pregnancy and offspring development","volume":"14","author":"Abruzzese","year":"2022","journal-title":"WIREs Mech Dis"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.4274\/jtgga.galenos.2024.2024-2-9","article-title":"Basal serum luteinizing hormone, total testosterone, and free testosterone levels do not impact IVF outcomes in patients with polycystic ovary syndrome","volume":"25","author":"Kugelman","year":"2024","journal-title":"J Turk Ger Gynecol Assoc"},{"key":"B25","doi-asserted-by":"publisher","first-page":"618","DOI":"10.1186\/s12884-023-05944-4","article-title":"Effect of basal luteinizing hormone (bLH) level on in vitro fertilization\/intra-cytoplasmic injections (IVF\/ICSI) outcomes in polycystic ovarian syndrome (PCOS) patients","volume":"23","author":"Liu","year":"2023","journal-title":"BMC Pregnancy Childbirth"},{"key":"B26","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1186\/s13048-025-01899-6","article-title":"Effects of high basal luteinizing hormone levels on in vitro fertilization\/intra-cytoplasmic injection outcomes in polycystic ovarian syndrome: a retrospective study","volume":"18","author":"Peng","year":"2025","journal-title":"J Ovarian Res"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/s1472-6483(10)61991-8","article-title":"LH in the follicular phase: neither too high nor too low","volume":"12","author":"Balasch","year":"2006","journal-title":"Reprod BioMed Online"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.7717\/peerj.18635","article-title":"Effect of basal luteinizing hormone\/follicle-stimulating hormone ratio on clinical outcome of in vitro fertilization in patients with polycystic ovarian syndrome: a retrospective cohort study","volume":"12","author":"Shan","year":"2024","journal-title":"PeerJ"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.3390\/jcm11164670","article-title":"Does serum LH level influence IVF outcomes in women with PCOS undergoing GnRH-antagonist stimulation: a novel indicator","volume":"11","author":"Wang","year":"2022","journal-title":"J Clin Med"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3892\/mmr.2015.3904","article-title":"Recombinant LH supplementation during IVF cycles with a GnRH-antagonist in estimated poor responders: a cross-matched pilot investigation of the optimal daily dose and timing","volume":"12","author":"Gizzo","year":"2015","journal-title":"Mol Med Rep"},{"key":"B31","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1111\/cen.12886","article-title":"The effect of LH supplementation to the GnRH antagonist protocol in advanced reproductive ageing women: a prospective randomized controlled study","volume":"84","author":"Younis","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"B32","doi-asserted-by":"publisher","first-page":"12907","DOI":"10.1038\/s41598-020-69325-z","article-title":"LH supplementation of ovarian stimulation protocols influences follicular fluid steroid composition contributing to the improvement of ovarian response in poor responder women","volume":"10","author":"Marchiani","year":"2020","journal-title":"Sci Rep"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1007\/s10815-012-9893-9","article-title":"Follicular fluid hormonal profile and cumulus cell gene expression in controlled ovarian hyperstimulation with recombinant FSH: effects of recombinant LH administration","volume":"29","author":"Barberi","year":"2012","journal-title":"J Assist Reprod Genet"},{"key":"B34","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1016\/s1472-6483(10)60758-4","article-title":"Recombinant LH supplementation to recombinant FSH during induced ovarian stimulation in the GnRH-antagonist protocol: a meta-analysis","volume":"14","author":"Baruffi","year":"2007","journal-title":"Reprod BioMed Online"},{"key":"B35","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.freeradbiomed.2022.05.010","article-title":"Mitochondrial and glucose metabolic dysfunctions in granulosa cells induce impaired oocytes of polycystic ovary syndrome through Sirtuin 3","volume":"187","author":"Zhang","year":"2022","journal-title":"Free Radic Biol Med"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1080\/09513590.2025.2610550","article-title":"Endometrial receptivity in polycystic ovary syndrome: altered biomarkers and underlying mechanisms","volume":"42","author":"Chi","year":"2026","journal-title":"Gynecol Endocrinol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/biomedicines11123150","article-title":"Elevated anti-M\u00fcllerian hormone as a prognostic factor for poor outcomes of in vitro fertilization in women with polycystic ovary syndrome","volume":"11","author":"Vale-Fernandes","year":"2023","journal-title":"Biomedicines"},{"key":"B38","doi-asserted-by":"publisher","first-page":"R29","DOI":"10.1093\/ejendo\/lvaf062","article-title":"Should anti-M\u00fcllerian hormone be a diagnosis criterion for polycystic ovary syndrome? An in-depth review of pros and cons","volume":"192","author":"Vale-Fernandes","year":"2025","journal-title":"Eur J Endocrinol"},{"key":"B39","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12958-022-00985-4","article-title":"Recombinant LH supplementation improves cumulative live birth rates in the GnRH antagonist protocol: a multicenter retrospective study using a propensity score-matching analysis","volume":"20","author":"Wang","year":"2022","journal-title":"Reprod Biol Endocrinol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.1056\/nejmoa1513873","article-title":"Fresh versus frozen embryos for infertility in the polycystic ovary syndrome","volume":"375","author":"Chen","year":"2016","journal-title":"N Engl J Med"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2026.1793202","article-title":"Assessment indicators of ovarian response during controlled ovarian stimulation: influencing factors and clinical value","volume":"17","author":"Xu","year":"2026","journal-title":"Front Endocrinol"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1909206\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T05:36:12Z","timestamp":1789968972000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1909206\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,21]]},"references-count":41,"alternative-id":["10.3389\/fendo.2026.1909206"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1909206","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,21]]},"article-number":"1909206"}}